Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542750 · ClinicalTrials.gov registry record · Phase 1
An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents
A Phase 1 study of Cannabis Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00542750 is a Phase 1 study of Cannabis Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants, below the 129-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00542750, a Phase 1 study of Cannabis Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine the feasibility of conducting a trial of N-Acetylcysteine in cannabis dependent adolescents.
Conditions Studied
Interventions
- DRUG N-Acetylcysteine
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542750
The ClinicalTrials.gov registry entry for NCT00542750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (81% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cannabis Dependence appearing as the primary indexed condition, and to 1 intervention - of which N-Acetylcysteine is the first listed.
NCT00542750 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT00542750 about?
NCT00542750 is a clinical study titled "An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents". The purpose of this pilot study is to determine the feasibility of conducting a trial of N-Acetylcysteine in cannabis dependent adolescents.
What is the current status of trial NCT00542750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-01. Estimated completion is 2008-12.
What conditions does trial NCT00542750 study?
This clinical trial studies the following conditions: Cannabis Dependence.
What interventions are being tested in trial NCT00542750?
The interventions under investigation include: N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00542750?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00542750 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RECRUITING
-
Neuroimaging of Adolescent Cannabis Use Treatment
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
COMPLETED · Phase 4
-
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.